Related Experiment Video
Updated: Jun 14, 2025
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
A cross-sectional study on gut microbiota and inflammation in patients with chronic kidney disease
Bruna R Paiva1, Júnia Schultz2, Fluvio Modolon3
1Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
Background:
This study investigated the inflammatory and gut microbiota profile in chronic kidney disease (CKD) patients undergoing hemodialysis (HD) and peritoneal dialysis (PD).
Methods:
A total of 249 patients undergoing HD and 61 patients on PD participated in the study. The mRNA expressions of nuclear factor erythroid 2-related factor-2 (NRF2), nuclear factor-κappa B (NF-κB), mitochondrial transcription factor A (TFAM), peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) were evaluated in peripheral blood mononuclear cells (PBMCs) by quantitative real-time PCR. Malondialdehyde (MDA), interleukin 6 (IL-6), and routine biochemical parameters were also analyzed. The fecal DNA extraction was performed, and the V4 regions of the bacterial 16S ribosomal RNA gene were sequenced. Uremic toxins such as p-cresyl sulfate (p-CS), indoxyl sulfate (IS), and indole-3-acetic acid (IAA) plasma levels were determined by HPLC.
Results:
MDA, IS, and p-CS levels were lower in PD than in HD patients. The mRNA expression of the transcription factors was not different between groups. Gut microbial α-diversity indices showed no significant difference between groups, but the β-diversity was different in PD patients. Members of the genera Meditarraneibacter, Roseburia, Agathobacter, Anaerobutyricum, Collinsella, Streptococcus, Clostridium, and Bacteroides, as well as the families Lachnospiraceae and Enterobacteriaceae, appear to be positively correlated with most dietary factors, particularly lipid and phosphorus intake.
Conclusions:
Our findings indicate that in patients with CKD on HD, there is increased plasma retention of uremic toxins and reduced gut microbial diversity compared to PD patients.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...